Australasian Psychiatry最新文献_第4页

From the President. 来自总统。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-10-01 Epub Date: 2026-10-09 DOI: 10.1177/10398562261486993

引用次数: 0

A retrospective pre- and post-analysis of the frequency of restrictive interventions in inpatient psychiatric units following the introduction of the Victorian Mental Health and Wellbeing Act 2022. 对实施《2022年维多利亚州精神健康和福利法案》后住院精神病病房限制性干预频率的回顾性前后分析。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-30 DOI: 10.1177/10398562261492550

Liam Hardcastle, Thy Nguyen, Karen Phillips, Jianyi Zhang, Evan Symons, Simon Stafrace, Toby Winton-Brown

{"title":"A retrospective pre- and post-analysis of the frequency of restrictive interventions in inpatient psychiatric units following the introduction of the Victorian Mental Health and Wellbeing Act 2022.","authors":"Liam Hardcastle, Thy Nguyen, Karen Phillips, Jianyi Zhang, Evan Symons, Simon Stafrace, Toby Winton-Brown","doi":"10.1177/10398562261492550","DOIUrl":"https://doi.org/10.1177/10398562261492550","url":null,"abstract":"IntroductionThe Mental Health and Wellbeing Act (MHWA) 2022 was a key recommendation of the Royal Commission into Victoria's Mental Health System. An objective of the act was to reduce the use of restrictive interventions in public mental health settings.MethodsThis retrospective pre-post analysis examined the frequency of restrictive interventions from hospital admission data on all patients admitted to two adult and one older adult inpatient mental health ward in the 12 months prior to and following the implementation of the MHWA 2022 on the 1st of September 2023.ResultsIn the year pre and post the MHWA 2022s initial implementation, there was no significant change to the incidence of restraint (mechanical and physical) (p = .98) or the probability of a patient being restrained at any time during their admission (p = .63). There was no significant change to the incidence of seclusion (p = .80) or the probability of a patient being secluded at any time during their admission (p = .54).ConclusionThere was no significant difference in the frequency of restraint or seclusion in the studied inpatient units at 1 year following the initial introduction of the MHWA 2022. Further research should assess more broadly the impact of the MHWA 2022.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261492550"},"PeriodicalIF":1.7,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149079476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Whīria moe: a pilot trial of the Sleep Ninja CBT-I app for adolescents in Aotearoa, New Zealand. whutria moe：新西兰奥特罗阿青少年睡眠忍者CBT-I应用程序的试点试验。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-30 DOI: 10.1177/10398562261491672

Nicola M Ludin, Helena Challis, Matthew M D M Pawley, Sarah Fortune, Guy R Warman, Barbara Galland, Aliza Werner-Seidler, Sarah E Hetrick, Tania Cargo

{"title":"Whīria moe: a pilot trial of the Sleep Ninja CBT-I app for adolescents in Aotearoa, New Zealand.","authors":"Nicola M Ludin, Helena Challis, Matthew M D M Pawley, Sarah Fortune, Guy R Warman, Barbara Galland, Aliza Werner-Seidler, Sarah E Hetrick, Tania Cargo","doi":"10.1177/10398562261491672","DOIUrl":"https://doi.org/10.1177/10398562261491672","url":null,"abstract":"ObjectiveDigital sleep interventions offer scalable early mental health support for youth. This study evaluated the feasibility and preliminary impact of Sleep Ninja, a self-guided Cognitive Behavioural Therapy for Insomnia (CBT-I) app, on insomnia and depression symptoms among adolescents in Aotearoa, New Zealand.MethodParticipants aged 16-18 (n = 47, 11% Māori, n = 5) with a self-reported desire to improve sleep were recruited via social media and snowball sampling. Users engaged with the app for 30 days. Online assessments of insomnia, depression, and well-being occurred at baseline, post-intervention (30 days), and follow-up (90 days). App acceptability and feasibility were explored via the User Version of the Mobile Application Rating Scale (uMARS) and qualitative interviews (n = 7).ResultsQuantitative results showed high app acceptability (uMARS) and feasibility, with participants engaging for an average of 17 days. Significant improvements in insomnia and depression symptoms and well-being were observed at 30 days, with some effects sustained at 90 days. Qualitative interviews further supported acceptability; participants emphasised the importance of cultural relevance and suggested incorporating Te Reo Māori to enhance engagement.ConclusionsSleep Ninja is acceptable to adolescents in Aotearoa, New Zealand. Preliminary results suggest improvements in insomnia, depression, and well-being, supporting further evaluation in a larger trial.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491672"},"PeriodicalIF":1.7,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149079471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hepatitis C screening in mental health services - A retrospective study of pathology testing, risk factors and positivity rates. 精神卫生机构的丙型肝炎筛查——病理检查、危险因素和阳性率的回顾性研究

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-29 DOI: 10.1177/10398562261491651

Cathy Ngo, Stephen Bloom, Rohit Sawhney, Geoffrey Haar, Robbie Chan, Judith Hope

{"title":"Hepatitis C screening in mental health services - A retrospective study of pathology testing, risk factors and positivity rates.","authors":"Cathy Ngo, Stephen Bloom, Rohit Sawhney, Geoffrey Haar, Robbie Chan, Judith Hope","doi":"10.1177/10398562261491651","DOIUrl":"https://doi.org/10.1177/10398562261491651","url":null,"abstract":"ObjectiveTo quantify Hepatitis C virus (HCV) testing, positivity rates and risk factor prevalence in mental health service consumers.MethodThis retrospective study (March 2019-April 2020) included consumers accessing mental health services at a public metropolitan hospital network. HCV testing was determined by data linkage with pathology results. Demographic characteristics, type of mental health care and assessment of HCV risk factors were analysed to investigate predictors of HCV positivity.ResultsEleven percent (n = 2065) of consumers had HCV testing; most commonly among inpatient-only consumers (22.6%; n = 513) and least common among community-only consumers (5.3%; n = 1,040). HCV antibody (Ab) positivity was observed in 31.2% of consumers (n = 215). Among those who underwent PCR testing (n = 42), 33.3% were PCR-positive.Predictors of active HCV infection were persons who injected drugs (PWID), evidence of liver disease and recent contact with custodial settings. Forty-three percent of consumers without HCV testing had at least one known HCV risk factor.ConclusionThe high HCV (Ab and RNA) positivity rate and prevalence of risk factors support consideration for increased screening in mental health services as a public health strategy to meet Australia's target of HCV eradication by 2030.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491651"},"PeriodicalIF":1.7,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Concurrent use of two long-acting injectable (LAI) antipsychotics in forensic patients with treatment-resistant schizophrenia: A case series. 同时使用两种长效注射（LAI）抗精神病药物治疗难治性精神分裂症的法医学患者：一个病例系列。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-29 DOI: 10.1177/10398562261491655

Asiri Rodrigo, Jacques Claassen, Daveena Mawren

{"title":"Concurrent use of two long-acting injectable (LAI) antipsychotics in forensic patients with treatment-resistant schizophrenia: A case series.","authors":"Asiri Rodrigo, Jacques Claassen, Daveena Mawren","doi":"10.1177/10398562261491655","DOIUrl":"https://doi.org/10.1177/10398562261491655","url":null,"abstract":"ObjectiveDescribe concurrent use of two long-acting injectable (LAI) antipsychotics in selected patients with treatment-resistant schizophrenia and persistent aggression at a forensic health facility. Evidence remains limited for this off-licence strategy.MethodsRetrospective case series conducted at a specialist forensic psychiatric hospital in Melbourne, Australia. All inpatients using concurrent LAI antipsychotics between March 2022 and March 2023 were included (N = 26). De-identified clinical data, including information for behavioral outcomes (Dynamic Appraisal of Situational Aggression [DASA]), institutional incidents, adverse effects and Defined Daily Dose (DDD) were extracted. Analyses were descriptive with exploratory unadjusted odds ratios.ResultsConcurrent LAI antipsychotics were predominantly prescribed to males (24/26, 92.3%) with chronic schizophrenia. Persistent aggression (22/26, 84.6%) was the commonest indication. Most frequent combination was olanzapine pamoate and zuclopenthixol decanoate and DDD median was 2.17 (range 0.48-10.13). Although the study design precluded identifying causal relationships, improvements were observed in DASA scores (21/26, 80.8%), incident frequency (22/26, 84.6%), and as-required-medication use (19/26, 73.1%). Adverse effects were common.ConclusionsSelected forensic patients with high-risk behaviors may benefit from concurrent LAI antipsychotics. Enhanced side-effect monitoring and multidisciplinary oversight are required when used. Data interpretation was limited by observational design, concomitant medications, and absence of standardized symptom measures.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261491655"},"PeriodicalIF":1.7,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149079521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Motion, emotion and cognition: The melancholia conundrum. 运动、情感和认知：忧郁症的难题。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-28 DOI: 10.1177/10398562261493821

Perminder S Sachdev

{"title":"Motion, emotion and cognition: The melancholia conundrum.","authors":"Perminder S Sachdev","doi":"10.1177/10398562261493821","DOIUrl":"https://doi.org/10.1177/10398562261493821","url":null,"abstract":"BackgroundThe status of melancholia remains controversial. Debate has focused on whether it represents a categorically distinct disorder (binary model) or a severe expression within a unitary construct of major depressive disorder. Its defining core has also been disputed, with competing emphasis on affective symptoms, cognitive distortions, or psychomotor disturbance. Proponents of distinctiveness, notably Gordon Parker, have argued that psychomotor disturbance is central to the syndrome.ObjectiveTo critically examine historical and contemporary evidence regarding melancholia's diagnostic status and to consider whether advances in neurobiology can resolve longstanding conceptual debates.MethodThis narrative analysis reviews the evolution of the melancholia construct, clinical and treatment-response data, research on psychomotor disturbance including the CORE measure, and recent findings from genetics, molecular psychiatry, and neuroimaging studies of brain networks implicated in depression.ConclusionPhenomenological and biomarker-based approaches have not conclusively established melancholia as a distinct nosological entity. Emerging findings from circuit neuroscience and multiomic research suggest that patterns of large-scale network dysfunction may underlie the clinical syndrome, but have not yet established a reproducible circuit signature specific to melancholia. A biologically grounded, network-based framework could ultimately clarify the relationship between melancholia, psychomotor disturbance and broader depressive syndromes, moving the field beyond the binary-dimensional impasse.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261493821"},"PeriodicalIF":1.7,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Wearing many hats: The art of addiction psychiatry in private practice. 身兼数职：私人执业中的成瘾精神病学艺术。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-28 DOI: 10.1177/10398562261493835

Wole Akosile, Enrico Cementon, Kavita Seth, Basanth Kenchaiah

引用次数: 0

Identifying substance-use disorders in mental health services: Routine practice across an Australian state. 识别精神卫生服务中的物质使用障碍：澳大利亚州的常规实践。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-28 DOI: 10.1177/10398562261493840

John Reilly, Michael Lam, Grant Sara, Ed Heffernan

{"title":"Identifying substance-use disorders in mental health services: Routine practice across an Australian state.","authors":"John Reilly, Michael Lam, Grant Sara, Ed Heffernan","doi":"10.1177/10398562261493840","DOIUrl":"https://doi.org/10.1177/10398562261493840","url":null,"abstract":"BackgroundSubstance-use disorders (SUDs) are commonly seen in mental health services (MHSs) but inaccurate identification contributes to their inconsistent care. This study examines routine SUDs identification in Queensland's adult MHSs.MethodsRoutine completion of four SUDs identification methods in the statewide electronic health record for MHSs was measured over 4 years from November 2018. Prevalence of identified substance-use groups, defined for each measure, was measured and compared across sociodemographic groups in 58,724 adults.ResultsCompletion of specific identification measures varied markedly. Each measure identified different proportions of defined substance-use groups. The measures with specific substance prompts, a screening tool and clinical pathway, identified higher prevalence of harmful use than the measures of diagnosis and an outcome measure, which lack specific prompts.ConclusionsIndividual SUDs identification processes, including diagnosis, were variably completed, with low screening tool completion. They identified markedly different prevalence, higher for more structured tools. Structured specific screening tools may over-identify risk of SUDs. Care of SUDs in adult MHSs could be improved at individual clinician and service levels by clarifying care pathways to better support delivery of structured processes of screening and brief intervention and to enable targeted assessment and accurate diagnosis.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562261493840"},"PeriodicalIF":1.7,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gender-affirming care, critical thinking, humility, and the ethics of psychiatric interpretation: A response to Amos (2024, 2026). 性别确认护理，批判性思维，谦逊和精神病学解释的伦理：对阿莫斯的回应（2024年，2026年）。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-28 DOI: 10.1177/10398562261493843

Laurence Cobbaert

引用次数: 0

We must pay attention to the diagnostic validity of ADHD in Australia: It is fundamental to its accurate detection and equitable management. 我们必须重视ADHD在澳大利亚的诊断有效性：这是其准确发现和公平管理的基础。

IF 1.7 4区医学

Australasian Psychiatry Pub Date : 2026-09-27 DOI: 10.1177/10398562261491661

Kinga Szymaniak, Erica Bell, Gurubhaskar Shivakumar, Gin S Malhi

引用次数: 0